SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-24-036855
Filing Date
2024-04-29
Accepted
2024-04-29 08:35:49
Documents
8
Period of Report
2024-06-05

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT ea0204731-01.htm DEF 14A 1661788
2 GRAPHIC toprx_logo.jpg GRAPHIC 46776
3 GRAPHIC timage_001.jpg GRAPHIC 211851
4 GRAPHIC timage_002.jpg GRAPHIC 444577
5 GRAPHIC tbarchart_001.jpg GRAPHIC 336887
6 GRAPHIC tbarchart_002.jpg GRAPHIC 385332
7 GRAPHIC tproxy_001.jpg GRAPHIC 1487600
8 GRAPHIC tproxy_002.jpg GRAPHIC 1275676
  Complete submission text file 0001213900-24-036855.txt   7433234
Mailing Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453
Business Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453 248-651-6558
OptimizeRx Corp (Filer) CIK: 0001448431 (see all company filings)

IRS No.: 261265381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38543 | Film No.: 24886759
SIC: 7389 Services-Business Services, NEC
(CF Office: 07 Trade & Services)